How Our Drug Repurposing Services Can Help You ?

On an average, a new drug takes minimum 14 years to come into market;our Drug Repositioning Services’ approach can give your novel molecule or existing molecule a second chance with new target protein (s). This approach can accelerate the introduction of drug molecule into the market along with secondary effects predictions. This program let the new drug to enter into market speedily and that too with less cost.

Our Drug repositioning Services involves compound identification, compound acquisition, preclinical development, preclinical trials and licensing.

RASA’s Drug Repositioning Services Approaches are-

1. Drug-Drug Target-Disease Mapping: RASA Bioinformatic CRO Lab  Drug Repositioning services’ main approach use network based and system biology which includes- Pathway or network and target mechanism.Here, all the possible chains connecting drugs to disease(s) or target(s), gene-target pathways are used to build rich database.
2. Rule based Model and Structure Base Screening: RASA Bioinformatic Lab Drug repositioning services have Knowledge based and target based methods for drug re-purposing which includes high-throughput literature analysis and with comprehensive conduction of drug-target association, we have built 970 Pharmacological Index, for drug re-positioning and approximately 3500 protein targets.